Advance MarketWoRx Clients

DTC Assessment and Customer Relationship Marketing

Sub-team leader for Consumer Care Divisional Growth Strategy initiative. Team charged with evaluation of scientific potential to extend division’s existing chemical entities into new indication areas.

(Lisa Ruderman previous work as independent consultant)

Professional positioning and message platform.
Managed design and development of:
           Product launch materials
           Redesign of corporate logo and website
           Clinical names/logos and communication materials.

(Lisa Ruderman previous work as independent consultant)

 

Consumer strategy, positioning and multi-channel program development; metrics.

Strategic assessment and planning.

Strategic guidance on potential commercial opportunities.

New product development: consumer adherence; workshop for annual client meeting.

Lead commercial role on development of late stage acute care cardiovascular compound. Development of product strategy -- basis for target product profile, launch indication plan, and development of phase 3 clinical program. Development projects for brand name, product video, clinical communications materials Lead inventor on patent application – to provide basis for innovative means to expand product label.

(Lisa Ruderman previous work as independent consultant)

Strategic assessment; external interviews and strategy implications.

Evaluations of global commercial opportunity for eight compounds - early development stage through phase 2 - in the rheumatology, pain and respiratory categories. Recommendation of Minimum (MPP) and Target Product Profiles (TPP) based on work with cross-functional project teams.
Recommendation of cardiovascular compound’s indication strategy based upon leadership of internal cross-functional team’s assessment. Included management of primary research program, leading to sales forecast modeling and financial cross-comparison of alternatives.
Commercial due diligence assessments (partnered with scientific team assessments) on potential global in-licensing late-stage compounds across multiple categories: incontinence, oral analgesics and CV-nephropathy.

(Lisa Ruderman previous work as independent consultant)

ADHD portfolio: Adderall XR, Daytrana and Vyvanse Pediatric/Adult; Rx Div CRM Strategy & Implementation.

DTC assessment for established brand; Consumer DTC/P launch strategy, planning & implementation, including positioning, multi-channel awareness and relationship marketing programs, and metrics; CRM strategy and recommendations for three launch brands Prescription CRM strategy and implementation: CRM strategy and recommendations; Database RFP and on-boarding.

Initial DTC strategic assessment of in-market program; segmentation, positioning, TV/web strategy. Follow-on initiative: business re-plan to achieve annual objectives.

Consumer strategy and positioning; market research design and interpretation for concept and pricing evaluation, for a direct-to-consumer hearing device.
 

Strategic assessment and refinement of consumer positioning and launch plan for Cimzia anti-TNF biologic in Rheumatoid Arthritis (RA) and Crohn’s disease (CD). Developed new national advertising campaign for RA [launch of indication] and for CD. Created highly successful Unbranded Direct Response National TV campaign for RA patients.

New pitch support, agency strategy and process improvements.